Surface Treatment of SARS-Infected Lungs

發明權利要求

PCT/SG03/00145

Claims A

(Use for medicine patent by patent-law of country only)

1. The liquid medicine name of “Surface Treatment of SARS–Infected Lungs” is Per Fluoro Chemicals (PFC) mixing ozone forming a medicine.

2. In the claim 1, the liquid includes all liquids of fluorine element.

3. In the claim 1, includes any substitute liquid to mixing ozone or the single oxygen is decompose by other element.

4. In the Claim 1 of liquid medicines include the option of mixing any chemical that might kill or restrain the germs, for instance any antibiotics or other bactericide and so on.

5. In the Claim 1, includes any other lung diseases and SARS inflammation.

1	肺部表面處理法的液體藥品學名爲液態的全氟化合物(Per fluoro chemicals, PFC) 混合臭氧(O3)。
2	在要求1. 的藥物液體特微為含氟元素的液體及單氧O1殺菌劑的產生。
3	在要求1 的應用包括PFC或其他代用液體中混合臭氧或促成產生單氧O1的元素。
4	在要求1. 的液態為介質的藥物的表面處理液添加殺害或抑制病菌的因素，包括其他抗生素或殺菌劑的注入。
5	在要求1. 的肺部表面處理法的液體藥包括非典型病菌感染的其他任何肺臟表面感染的疾病。